171 related articles for article (PubMed ID: 3933818)
1. A phase I trial of recombinant gamma interferon in patients with cancer.
Foon KA; Sherwin SA; Abrams PG; Stevenson HC; Holmes P; Maluish AE; Oldham RK; Herberman RB
Cancer Immunol Immunother; 1985; 20(3):193-7. PubMed ID: 3933818
[TBL] [Abstract][Full Text] [Related]
2. A preliminary Phase I trial of partially purified interferon-gamma in patients with cancer.
Sherwin SA; Foon KA; Abrams PG; Heyman MR; Ochs JJ; Watson T; Maluish A; Oldham RK
J Biol Response Mod; 1984 Dec; 3(6):599-607. PubMed ID: 6439828
[TBL] [Abstract][Full Text] [Related]
3. A phase I trial with recombinant interferon gamma (Roussel UCLAF) in advanced cancer patients.
Boue F; Pastran Z; Spielmann M; Le Chevalier T; Subirana R; Sevin D; Paoletti C; Brandely M; Avril MF; Sancho-Garnier H
Cancer Immunol Immunother; 1990; 32(1):67-70. PubMed ID: 2126985
[TBL] [Abstract][Full Text] [Related]
4. A Southwest Oncology Group Phase I study of the sequential combination of recombinant interferon-gamma and recombinant interleukin-2 in patients with cancer.
Taylor CW; Chase EM; Whitehead RP; Rinehart JJ; Neidhart JA; Gonzalez R; Bunn PA; Hersh EM
J Immunother (1991); 1992 Apr; 11(3):176-83. PubMed ID: 1515422
[TBL] [Abstract][Full Text] [Related]
5. Phase II trial of a combination of interferon-beta ser and interferon-gamma in patients with advanced malignant melanoma.
Schiller JH; Storer B; Bittner G; Willson JK; Borden EC
J Interferon Res; 1988 Oct; 8(5):581-9. PubMed ID: 3148669
[TBL] [Abstract][Full Text] [Related]
6. Phase I study of a combination of recombinant interferon-alpha and recombinant interferon-gamma in cancer patients.
Kurzrock R; Rosenblum MG; Quesada JR; Sherwin SA; Itri LM; Gutterman JU
J Clin Oncol; 1986 Nov; 4(11):1677-83. PubMed ID: 3095504
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-2 in association with increasing doses of interferon-gamma in patients with advanced cancer.
Viens P; Blaise D; Stoppa AM; Brandely M; Baume D; Olive D; Resbeut M; Delpero JR; Lopez M; Aubert C
J Immunother (1991); 1992 Apr; 11(3):218-24. PubMed ID: 1515426
[TBL] [Abstract][Full Text] [Related]
8. Recombinant interferon-gamma (immuneron): results of a phase I trial in patients with cancer.
van der Burg M; Edelstein M; Gerlis L; Liang CM; Hirschi M; Dawson A
J Biol Response Mod; 1985 Jun; 4(3):264-72. PubMed ID: 3926954
[TBL] [Abstract][Full Text] [Related]
9. Phase I trial of recombinant interferon gamma by 1-hour i.v. infusion.
Vadhan-Raj S; Nathan CF; Sherwin SA; Oettgen HF; Krown SE
Cancer Treat Rep; 1986 May; 70(5):609-14. PubMed ID: 3085930
[TBL] [Abstract][Full Text] [Related]
10. A phase I study of recombinant interleukin 2 plus recombinant beta-interferon.
Krigel RL; Padavic-Shaller KA; Rudolph AR; Litwin S; Konrad M; Bradley EC; Comis RL
Cancer Res; 1988 Jul; 48(13):3875-81. PubMed ID: 3132324
[TBL] [Abstract][Full Text] [Related]
11. Phase I/II trial of human recombinant interferon gamma in renal cell carcinoma.
Rinehart JJ; Malspeis L; Young D; Neidhart JA
J Biol Response Mod; 1986 Aug; 5(4):300-8. PubMed ID: 3090208
[TBL] [Abstract][Full Text] [Related]
12. Biological and clinical effects of the combination of beta- and gamma-interferons administered as a 5-day continuous infusion.
Schiller JH; Storer B; Witt PL; Nelson B; Brown RR; Horisberger M; Grossberg S; Borden EC
Cancer Res; 1990 Aug; 50(15):4588-94. PubMed ID: 2114942
[TBL] [Abstract][Full Text] [Related]
13. Phase I study of i.v. administered recombinant gamma interferon in cancer patients.
Kurzrock R; Quesada JR; Rosenblum MG; Sherwin SA; Gutterman JU
Cancer Treat Rep; 1986 Dec; 70(12):1357-64. PubMed ID: 3098417
[TBL] [Abstract][Full Text] [Related]
14. Phase I trial of recombinant interferon gamma in cancer patients.
Vadhan-Raj S; Al-Katib A; Bhalla R; Pelus L; Nathan CF; Sherwin SA; Oettgen HF; Krown SE
J Clin Oncol; 1986 Feb; 4(2):137-46. PubMed ID: 3080551
[TBL] [Abstract][Full Text] [Related]
15. A toxicity study of recombinant interferon-gamma given by intravenous infusion to patients with advanced cancer.
Sriskandan K; Garner P; Watkinson J; Pettingale KW; Brinkley D; Calman FM; Tee DE
Cancer Chemother Pharmacol; 1986; 18(1):63-8. PubMed ID: 3093108
[TBL] [Abstract][Full Text] [Related]
16. Phase II studies of recombinant human interferon gamma in metastatic renal cell carcinoma.
Quesada JR; Kurzrock R; Sherwin SA; Gutterman JU
J Biol Response Mod; 1987 Feb; 6(1):20-7. PubMed ID: 3104544
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics, single-dose tolerance, and biological activity of recombinant gamma-interferon in cancer patients.
Kurzrock R; Rosenblum MG; Sherwin SA; Rios A; Talpaz M; Quesada JR; Gutterman JU
Cancer Res; 1985 Jun; 45(6):2866-72. PubMed ID: 3921249
[TBL] [Abstract][Full Text] [Related]
18. A phase I study of recombinant human interleukin-2 and alpha-interferon-2a in patients with renal cell cancer, colorectal cancer, and malignant melanoma.
Mittelman A; Huberman M; Puccio C; Fallon B; Tessitore J; Savona S; Eyre R; Gafney E; Wick M; Skelos A
Cancer; 1990 Aug; 66(4):664-9. PubMed ID: 2386896
[TBL] [Abstract][Full Text] [Related]
19. A phase I trial of recombinant human gamma interferon (IFN-gamma 4A) in patients with advanced malignancy.
Perez R; Lipton A; Harvey HA; Simmonds MA; Romano PJ; Imboden SL; Giudice G; Downing MR; Alton NK
J Biol Response Mod; 1988 Jun; 7(3):309-17. PubMed ID: 3134513
[TBL] [Abstract][Full Text] [Related]
20. [Phase I-II study of recombinant interferon gamma].
Adachi K; Ogawa M; Usui N; Inagaki J; Horikoshi N; Inoue K; Nakada H; Tada A; Yamazaki H; Mukaiyama T
Gan To Kagaku Ryoho; 1985 Jun; 12(6):1331-8. PubMed ID: 2988459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
